R. Reilmann, A. Feigin, A. Rosser, S. Kostyk, M. Geva, Noga Gershoni-Emek, D. Boot, Yael Cohen, Y. P. Goldberg, M. R. Hayden
{"title":"J09 An update on the proof-HD phase 3 trial: pridopidine’s outcome on function in huntington","authors":"R. Reilmann, A. Feigin, A. Rosser, S. Kostyk, M. Geva, Noga Gershoni-Emek, D. Boot, Yael Cohen, Y. P. Goldberg, M. R. Hayden","doi":"10.1136/jnnp-2022-ehdn.259","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":251913,"journal":{"name":"J: Clinical therapeutics","volume":"362 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"J: Clinical therapeutics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/jnnp-2022-ehdn.259","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
